A 23 yrs old patient presented in unconscious state with subsequent development of extrapyramidal symptoms and hyperthermia. On investigations, he was found to have high CPK levels. He was treated with dopaminergic drugs and improved. Later history of intake of stemetil and antipsychotics was found.
Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic Malignant Syndrome In: Joseph Anthony B, Young Robert R. Movement disorders in Neurology and Neuropsychiatry. 2nd ed. Blackwell Sciences: 1999.
Desai ND, Mundra VK, Gore YS, Diwan PJ, Jaydeokar SS, Jain V, et al. Neuroleptic malignant syndrome: An experience of four cases. J Assoc Physic India 1998;46:653-4.
Pinto C. Neuroleptic malignant syndrome: An experience of four cases. J Assoc Physicians India 1998;46:585-6.
Gohel D, Shah J, Jhaver U. Neuroleptic Malignant syndrome. J Assoc Physic India 2001;49:494.
Gohel D, Mukherjee S. Neuroleptic Malignant syndrome-atypical presentations. J Assoc Physic India 2001;49:947-8.
Tarsy D, Baldessarini RJ, Tarazi FI. Effects of newer antipsychotics on extra pyramidal functions. CNS Drugs 2002;16:23-45.
Caroff SN, Rosenberg H, Mann SC. Neuroleptic Malignant syndrome in the critical care unit. Crit Care Med 2002;11:2609-10.
Berardi D, Amore M, Keck PE Jr, Troia M, Dell′Atti M. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: A case-control study. Biol Psychiatr 1998;44:748-54.
